Maddocks advises Optus in copper network access matter
Maddocks has advised Optus in its successful defence against Telstra to higher rates for access to the Telstra copper network.
Tuesday 28 March 2017
Maddocks has advised telecommunications leader Optus in its successful defence against attempts by Telstra to charge it and other telecommunications companies a higher rate for access to the Telstra copper network.
In a significant win for consumers, the Federal Court today confirmed an earlier decision by the Australian Competition and Consumer Commission that Telstra would need to lower the access price paid by rival telcos to access Telstra's copper network by 9.4 percent.
The Maddocks team on the matter was led by partners Brendan Coady and Norman Lucas.
Brendan said that the ACCC's original decision hinged on how Telstra was able to recoup costs associated with the rollout of the National Broadband Network.
'Telstra argued that the unit costs for maintaining the network would increase as less people would be using its network as they migrated to the NBN. This meant that Telstra lost the opportunity to exploit certain economies of scale,' Brendan said.
'The ACCC determined – and the Federal Court today has confirmed – that Telstra had the opportunity to be compensated for these costs during its commercial negotiations with NBN Co. and that these costs should not be passed on to other telcos and, ultimately, consumers.'
Keep up to date with our legal insights and events
Sign upRecent articles
Maddocks recognised as leading firm in inaugural legal rankings
Maddocks has been recognised in the 2024 Law Firms of the Year by Australasian Lawyer and NZ Lawyer.
Maddocks advises on Click Click Marketing sale
Maddocks has advised the founder of Click Click Marketing on a sell-down to private equity firm Straight Bat.
Maddocks advises on professional services sale
The sale of management consulting firm Exent to ASX-listed professional services company Atturra Limited.
Maddocks advises on sale of bWellness
The sale will allow ASX-listed Nuchev, which specialises in goat milk products, to expand into complementary healthcare.
Consultant
Sydney